# Artificial Intelligence Technology Solutions Inc.: financial statements, quarterly

AITX · OTC · CIK 1498148 · [Technology](/sectors/technology.md) · fiscal year ends Feb 28

Pages: [Overview](/companies/aitx.md) · [Financials](/companies/aitx/financials.md) · [Filings](/companies/aitx/filings.md) · [Insiders](/companies/aitx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aitx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [597](/filings/0001493152-25-002128.md) | [859 d](/filings/0001641172-25-012903.md) | [1,183](/filings/0001641172-25-019701.md) | [1,344](/filings/0001493152-25-018105.md) | [1,751](/filings/0001493152-26-002249.md) | [1,853 d](/filings/0001493152-26-033600.md) | [1,855](/filings/0001493152-26-033603.md) | [1,889](/filings/0001493152-26-047759.md) | [2,010](/filings/0001493152-26-002249.md) | [1,992 d](/filings/0001493152-26-033600.md) | [1,831](/filings/0001493152-26-033603.md) | [1,986](/filings/0001493152-26-047759.md) |
| Cost of revenue | $k | [250](/filings/0001493152-25-002128.md) | [1,023 d](/filings/0001641172-25-012903.md) | [497](/filings/0001641172-25-019701.md) | [343](/filings/0001493152-25-018105.md) | [577](/filings/0001493152-26-002249.md) | [969 d](/filings/0001493152-26-033600.md) | [621](/filings/0001493152-26-033603.md) | [544](/filings/0001493152-26-047759.md) | [710](/filings/0001493152-26-002249.md) | [337 d](/filings/0001493152-26-033600.md) | [647](/filings/0001493152-26-033603.md) | [922](/filings/0001493152-26-047759.md) |
| Gross profit | $k | [347](/filings/0001493152-25-002128.md) | [(164) d](/filings/0001641172-25-012903.md) | [685](/filings/0001641172-25-019701.md) | [1,001](/filings/0001493152-25-018105.md) | [1,174](/filings/0001493152-26-002249.md) | [884 d](/filings/0001493152-26-033600.md) | [1,234](/filings/0001493152-26-033603.md) | [1,345](/filings/0001493152-26-047759.md) | [1,300](/filings/0001493152-26-002249.md) | [1,655 d](/filings/0001493152-26-033600.md) | [1,184](/filings/0001493152-26-033603.md) | [1,063](/filings/0001493152-26-047759.md) |
| Research and development | $k | [557](/filings/0001493152-25-002128.md) | [1,203 d](/filings/0001641172-25-012903.md) | [810](/filings/0001641172-25-019701.md) | [677](/filings/0001493152-25-018105.md) | [579](/filings/0001493152-26-002249.md) | [1,565 d](/filings/0001493152-26-033600.md) | [1,088](/filings/0001493152-26-033603.md) | [920](/filings/0001493152-26-047759.md) | [1,097](/filings/0001493152-26-002249.md) | [1,024 d](/filings/0001493152-26-033600.md) | [886](/filings/0001493152-26-033603.md) | [1,063](/filings/0001493152-26-047759.md) |
| Selling, general and administrative | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(2,385)](/filings/0001493152-25-002128.md) | [(5,610) d](/filings/0001641172-25-012903.md) | [(2,833)](/filings/0001641172-25-019701.md) | [(2,614)](/filings/0001493152-25-018105.md) | [(2,303)](/filings/0001493152-26-002249.md) | [(6,197) d](/filings/0001493152-26-033600.md) | [(3,179)](/filings/0001493152-26-033603.md) | [(2,309)](/filings/0001493152-26-047759.md) | [(2,632)](/filings/0001493152-26-002249.md) | [(3,824) d](/filings/0001493152-26-033600.md) | [(2,709)](/filings/0001493152-26-033603.md) | [(2,680)](/filings/0001493152-26-047759.md) |
| Interest expense | $k | [1,582](/filings/0001161697-24-000035.md) | [1,817 d](/filings/0001493152-24-021767.md) | [1,361](/filings/0001641172-25-019701.md) | [1,310](/filings/0001493152-25-018105.md) | [1,401](/filings/0001493152-26-002249.md) | [1,385 d](/filings/0001493152-26-033600.md) | [1,415](/filings/0001493152-26-033603.md) | [1,298](/filings/0001493152-26-047759.md) | [1,469](/filings/0001493152-26-002249.md) | [1,819 d](/filings/0001493152-26-033600.md) | [2,299](/filings/0001493152-26-033603.md) | [2,477](/filings/0001493152-26-047759.md) |
| Net income | $k | [(3,966)](/filings/0001493152-25-002128.md) | [(7,427) d](/filings/0001641172-25-012903.md) | [(4,194)](/filings/0001493152-26-002249.md) | [(3,930)](/filings/0001493152-26-002249.md) | [(3,704)](/filings/0001493152-26-002249.md) | [(7,107) d](/filings/0001493152-26-033600.md) | [(4,594)](/filings/0001493152-26-047759.md) | [763](/filings/0001493152-26-047759.md) | [(4,731)](/filings/0001493152-26-002249.md) | [(5,948) d](/filings/0001493152-26-033600.md) | [(5,716)](/filings/0001493152-26-047759.md) | [(6,838)](/filings/0001493152-26-047759.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001493152-25-002128.md) | not reported | [0.00](/filings/0001641172-25-019701.md) | [0.00](/filings/0001493152-25-018105.md) | [0.00](/filings/0001493152-26-002249.md) | not reported | [(0.03)](/filings/0001493152-26-033603.md) | [0.00](/filings/0001493152-26-047759.md) | [0.00](/filings/0001493152-26-002249.md) | not reported | [(0.02)](/filings/0001493152-26-033603.md) | [(0.02)](/filings/0001493152-26-047759.md) |
| Basic EPS | $ per share | [0.00](/filings/0001493152-25-002128.md) | not reported | [0.00](/filings/0001641172-25-019701.md) | [0.00](/filings/0001493152-25-018105.md) | [0.00](/filings/0001493152-26-002249.md) | not reported | [(0.03)](/filings/0001493152-26-033603.md) | [0.00](/filings/0001493152-26-047759.md) | [0.00](/filings/0001493152-26-002249.md) | not reported | [(0.02)](/filings/0001493152-26-033603.md) | [(0.02)](/filings/0001493152-26-047759.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-11-30) | FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001161697-24-000035.md) | [0.1](/filings/0001641172-25-012903.md) | [0.2](/filings/0001493152-24-027824.md) | [0.5](/filings/0001493152-24-041126.md) | [0.1](/filings/0001493152-25-002128.md) | [0.9](/filings/0001493152-26-033600.md) | [0.3](/filings/0001641172-25-019701.md) | [0.3](/filings/0001493152-25-018105.md) | [0.1](/filings/0001493152-26-002249.md) | [0.1](/filings/0001493152-26-047759.md) | [0.1](/filings/0001493152-26-033603.md) | [0.2](/filings/0001493152-26-047759.md) |
| Current assets | $m | [3.5](/filings/0001161697-24-000035.md) | [3.6](/filings/0001641172-25-012903.md) | [3.1](/filings/0001493152-24-027824.md) | [4.1](/filings/0001493152-24-041126.md) | [4.0](/filings/0001493152-25-002128.md) | [5.0](/filings/0001493152-26-033600.md) | [3.3](/filings/0001641172-25-019701.md) | [2.8](/filings/0001493152-25-018105.md) | [3.1](/filings/0001493152-26-002249.md) | [2.9](/filings/0001493152-26-047759.md) | [3.0](/filings/0001493152-26-033603.md) | [3.0](/filings/0001493152-26-047759.md) |
| Total assets | $m | [7.1](/filings/0001161697-24-000035.md) | [7.6](/filings/0001641172-25-012903.md) | [7.9](/filings/0001493152-24-027824.md) | [9.2](/filings/0001493152-24-041126.md) | [9.8](/filings/0001493152-25-002128.md) | [11.0](/filings/0001493152-26-033600.md) | [9.8](/filings/0001641172-25-019701.md) | [9.5](/filings/0001493152-25-018105.md) | [9.6](/filings/0001493152-26-002249.md) | [9.3](/filings/0001493152-26-047759.md) | [9.1](/filings/0001493152-26-033603.md) | [8.9](/filings/0001493152-26-047759.md) |
| Current liabilities | $m | [16.5](/filings/0001161697-24-000035.md) | [21.7](/filings/0001641172-25-012903.md) | [28.7](/filings/0001493152-24-027824.md) | [37.1](/filings/0001493152-24-041126.md) | [41.3](/filings/0001493152-25-002128.md) | [7.6](/filings/0001493152-26-033600.md) | [7.1](/filings/0001641172-25-019701.md) | [9.2](/filings/0001493152-25-018105.md) | [17.1](/filings/0001493152-26-002249.md) | [20.0](/filings/0001493152-26-047759.md) | [44.9](/filings/0001493152-26-033603.md) | [58.9](/filings/0001493152-26-047759.md) |
| Total liabilities | $m | [43.3](/filings/0001161697-24-000035.md) | [47.8](/filings/0001641172-25-012903.md) | [53.6](/filings/0001493152-24-027824.md) | [54.7](/filings/0001493152-24-041126.md) | [56.8](/filings/0001493152-25-002128.md) | [60.5](/filings/0001493152-26-033600.md) | [59.9](/filings/0001641172-25-019701.md) | [56.4](/filings/0001493152-25-018105.md) | [58.3](/filings/0001493152-26-002249.md) | [62.0](/filings/0001493152-26-047759.md) | [64.7](/filings/0001493152-26-033603.md) | [70.2](/filings/0001493152-26-047759.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [1.4](/filings/0001161697-24-000035.md) | [13.9](/filings/0001493152-24-021767.md) | [17.6](/filings/0001493152-24-027824.md) | [23.5](/filings/0001493152-24-041126.md) | [25.1](/filings/0001493152-25-002128.md) | [0.5](/filings/0001641172-25-012903.md) | [0.5](/filings/0001641172-25-019701.md) | [2.1](/filings/0001493152-25-018105.md) | [7.3](/filings/0001493152-26-002249.md) | [9.5](/filings/0001493152-26-033600.md) | [27.8](/filings/0001493152-26-033603.md) | [35.6](/filings/0001493152-26-047759.md) |
| Short-term borrowings | $m | [0.0](/filings/0001161697-24-000035.md) | [0.0](/filings/0001493152-24-041126.md) | [0.0](/filings/0001493152-24-027824.md) | [0.0](/filings/0001493152-24-041126.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(36.2)](/filings/0001493152-25-002128.md) | [(40.2)](/filings/0001493152-26-033600.md) | [(45.9)](/filings/0001493152-26-002249.md) | [(45.5)](/filings/0001493152-26-002249.md) | [(47.0)](/filings/0001493152-26-002249.md) | [(49.9)](/filings/0001493152-26-047759.md) | [(50.5)](/filings/0001493152-26-047759.md) | [(47.3)](/filings/0001493152-26-047759.md) | [(49.6)](/filings/0001493152-26-002249.md) | [(53.2)](/filings/0001493152-26-047759.md) | [(56.1)](/filings/0001493152-26-047759.md) | [(61.7)](/filings/0001493152-26-047759.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-11-30) | Q4 FY2024 (2024-02-29) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(3,043) d](/filings/0001493152-25-002128.md) | [(3,573) d](/filings/0001641172-25-012903.md) | [(3,046)](/filings/0001641172-25-019701.md) | [(3,388) d](/filings/0001493152-25-018105.md) | [(2,460) d](/filings/0001493152-26-002249.md) | [(3,302) d](/filings/0001493152-26-033600.md) | [(3,321)](/filings/0001493152-26-033603.md) | [(2,079) d](/filings/0001493152-26-047759.md) | [(2,051) d](/filings/0001493152-26-002249.md) | [(1,893) d](/filings/0001493152-26-033600.md) | [(2,759)](/filings/0001493152-26-033603.md) | [(2,062) d](/filings/0001493152-26-047759.md) |
| Capital expenditure | $k | [10.4 d](/filings/0001493152-25-002128.md) | [8.3 d](/filings/0001641172-25-012903.md) | [19.1](/filings/0001641172-25-019701.md) | [4.6 d](/filings/0001493152-25-018105.md) | [0.0 d](/filings/0001493152-26-002249.md) | [0.0 d](/filings/0001493152-26-033600.md) | [8.4](/filings/0001493152-26-033603.md) | [0.0 d](/filings/0001493152-26-047759.md) | [2.4 d](/filings/0001493152-26-002249.md) | [0.0 d](/filings/0001493152-26-033600.md) | [15.6](/filings/0001493152-26-033603.md) | [0.0 d](/filings/0001493152-26-047759.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2020 (2019-08-31) | Q1 FY2024 (2023-05-31) | Q2 FY2024 (2023-08-31) | Q3 FY2024 (2023-11-30) | Q1 FY2025 (2024-05-31) | Q2 FY2025 (2024-08-31) | Q3 FY2025 (2024-11-30) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | billions of shares | [0.0](/filings/0001161697-20-000443.md) | [6.0](/filings/0001493152-24-027824.md) | [6.6](/filings/0001493152-24-041126.md) | [7.3](/filings/0001493152-25-002128.md) | [9.9](/filings/0001641172-25-019701.md) | [11.2](/filings/0001493152-25-018105.md) | [12.2](/filings/0001493152-26-002249.md) | [0.2](/filings/0001493152-26-033603.md) | [0.9](/filings/0001493152-26-047759.md) | [21.8](/filings/0001493152-26-002249.md) | [0.3](/filings/0001493152-26-033603.md) | [0.5](/filings/0001493152-26-047759.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 861,808,211 at 2026-10-20, from the cover of the [10-Q filed 2026-10-20](/filings/0001493152-26-047759.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.